Multicenter validation of the CamGFR model for estimated glomerular filtration rate

Edward H. Williams, Claire M. Connell, James M.J. Weaver, Ian Beh, Harry Potts, Cameron T. Whitley, Nicholas Bird, Tamer Al-Sayed, Phillip J. Monaghan, Martin Fehr, Richard Cathomas, Gianfilippo Bertelli, Amy Quinton, Paul Lewis, Jonathan Shamash, Peter Wilson, Michael Dooley, Susan Poole, Patrick B. Mark, Michael A. BookmanHelena Earl, Duncan Jodrell, Simon Tavare, Andy G. Lynch, Tobias Janowitz

Research output: Contribution to journalArticleOtherpeer-review

6 Citations (Scopus)

Abstract

Important oncological management decisions rely on kidney function assessed by serum creatinine-based estimated glomerular filtration rate (eGFR). However, no large-scale multicenter comparisons of methods to determine eGFR in patients with cancer are available. To compare the performance of formulas for eGFR based on routine clinical parameters and serum creatinine not calibrated with isotope dilution mass spectrometry, we studied 3620 patients with cancer and 166 without cancer who had their glomerular filtration rate (GFR) measured with an exogenous nuclear tracer at one of seven clinical centers. The mean measured GFR was 86 mL/min. Accuracy of all models was center dependent, reflecting intercenter variability of isotope dilution mass spectrometry-creatinine measurements. CamGFR was the most accurate model for eGFR (root-mean-squared error 17.3 mL/min) followed by the Chronic Kidney Disease Epidemiology Collaboration model (root-mean-squared error 18.2 mL/min).

Original languageEnglish
Article numberpkz068
Number of pages4
JournalJNCI Cancer Spectrum
Volume3
Issue number4
DOIs
Publication statusPublished - 1 Dec 2019

Cite this